DigiPath, Inc., an independent cannabis testing and media firm, on Thursday announced that it has received approval from the state of Nevada for its DigiPath Labs subsidiary to open and operate a cannabis testing laboratory at 6450 Cameron Street, Suite 113, in Las Vegas.
DigiPath Labs is in the process of applying for construction permits, ordering equipment, and hiring staff in anticipation of opening the Cameron Street laboratory. To expedite construction, the company is working with a local architectural firm it engaged during the application process. The lab is expected to open its doors to customers in early 2015.
"We are grateful to the State of Nevada for helping to advance our goal of setting a new benchmark for medical cannabis testing and safety screening," said Todd Denkin, CEO of DigiPath, Inc.
"DigiPath Labs is dedicated to increasing transparency of the ingredients inside cannabis-based products," Denkin said. "We believe that this information will benefit patients and dispensaries by providing them with important information regarding the products being sold for consumption."
DigiPath Labs will screen medicinal cannabis for potentially harmful contaminants, including:
• Heavy metals, including mercury, arsenic, lead, and cadmium
• Biological toxins, such as aflatoxin, ricin, and botulinum toxins
• Residual organic chemicals used in extraction
• Microbial contaminants including E. coli, salmonella, and Aspergillus